Lumida
/MDGL
⌘K
Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

MDGL
$534.49USD+0.26%+1.37 today

MARKET CAP

12.3B

P/E (TTM)

FWD P/E

DAY RANGE

$531 – $547

52W RANGE

$394
$615

AI Summary

Stalk
StalkMedium

MDGL has formed a Stage 2 accumulation base, consolidating in a tight range above rising EMAs. Medium-term bias is bullish, favoring long entries on breakouts or high-conviction pullbacks. Short-term execution is on hold as price is extended above EMAs and near overbought conditions, warranting patience. Long-term trend remains intact above the 200 DMA.

  • Q2 revenue rose 71% YoY to $364.3M, driven by ResDifera demand.
  • ResDifera prescribed to over 49,000 patients, signaling robust market penetration.
  • Q2 net loss of $57.9M reflects SG&A expenses of $289.4M.
Full analysis →

Buying

7

institutions

Selling

9

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY4.04 M2.10 B+2.45 M+129.1%0.51%
BI

Blackrock, Inc.

Q2 2026

SELL1.20 M644.75 M+-359.19 K-21.0%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY688.13 K369.49 M+85.59 K+17.1%0.04%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL142.63 K76.58 M+-92.28 K-37.7%0.09%
WP

Woodline Partners LP

Q2 2026

SELL125.90 K67.60 M+-125.90 K-48.7%0.21%
MM

Millennium Management LLC

Q2 2026

BUY118.50 K63.63 M+77.64 K+197.5%0.02%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW79.01 K42.42 M+79.01 K+0.0%0.05%
RT

Renaissance Technologies LLC

Q2 2026

SELL45.94 K24.67 M+-25.93 K-34.4%0.03%
JC

Jpmorgan Chase & Co

Q2 2026

SELL29.47 K16.01 M+-6.84 K-12.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL29.02 K15.58 M+-4.83 K-12.1%0.02%
CP

California Public Employees Retirement System

Q2 2026

BUY24.28 K13.04 M+1.08 K+7.3%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL15.83 K8.50 M+-126.00+1.8%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW6.45 K3.46 M+6.45 K+0.0%0.03%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW2.10 K1.13 M+2.10 K+0.0%0.26%
EP

Eversept Partners, LP

Q2 2026

SELL0.000.00+-10.00 K-100.0%0.00%
BA

Bridgewater Associates, LP

Q2 2026

SELL0.000.00+-3.92 K-100.0%0.00%